Stocks To Buy Now Blog

All posts by Christopher

Nightfood Holdings Inc. (NGTF): Spearheading the Robotics-as-a-Service (‘RaaS’) Revolution in Hospitality

  • Nightfood Holdings has strategically entered the human assist solutions market by acquiring Future Hospitality Ventures, a pioneer in robotic solutions for the hospitality industry
  • The RaaS model offers cost efficiency, flexibility and simplified adoption, making it a lifeline for businesses facing existential threats due to labor shortages and rising operating costs.

The hospitality industry is undergoing a reckoning driven by out-of-control labor costs. Advancements in technology, such as Robotics-as-a-Service (“RaaS”), present the only viable way forward. This model allows food service and hospitality businesses to access cutting-edge service robots on a subscription basis, bypassing the prohibitive upfront costs that currently prevent many companies from being able to capitalize on the robotics revolution.

Nightfood Holdings (OTCQB: NGTF) recognized the existential crisis facing foodservice businesses in California, the world’s fifth largest economy. The company has strategically positioned itself as a pioneer in RaaS by acquiring Future Hospitality Ventures, a provider of robotic solutions on a subscription basis.

Nightfood’s Strategic Leap into RaaS

Nightfood Holdings’ acquisition of Future Hospitality Ventures marks a significant milestone in its growth trajectory. Future Hospitality is growing its brand, RoboOp365, with innovative robotic solutions that solve the most critical challenges in the hospitality industry: labor shortages, rising operating costs, and insatiable consumer demand for outstanding service experiences. This acquisition aligns perfectly with Nightfood’s commitment to innovation and shareholder value, positioning the company at the forefront of technological advancements in the sector.

Key Robotics-as-a-Service Solutions:

  • Front-End Service Robots: Future Hospitality’s service robotics are designed to complement human staff. They help with heavy lifting, reducing work related injuries, and help with other mundane repetitive tasks that do not require human labor. They ensure faster and reliable service delivery. These robots help streamline operations, minimize wait times for customers, and reduce human errors. This allows team personnel to focus on high-leverage, high value interpersonal engagements to truly provide a hospitable experience guests expect.
  • Back-End Kitchen Bots: The smart cooking bots offered by Future Hospitality revolutionize kitchen operations by ensuring consistent food quality and enabling anyone to make delicious meals quickly and efficiently. This technology resolves critical issues in busy kitchens, such as the requirement of training and hiring skilled cooks, food quality inconsistency and the strain of labor shortages and high labor costs.

The Broader Impact: RaaS as a Game-Changer

There’s an ongoing revolution making automation a necessity in the hospitality industry. Unfortunately, the high cost of robotics purchases and ownership has prevented many operators from being able to afford the investment in automation. Robotics-as-a-Service has emerged to fill that void, allowing operators and franchisees a lifeline to remaining viable.

RaaS Benefits:

  • Cost Efficiency: By offering robots on a subscription basis, RaaS lowers the financial costs of entry for businesses of all sizes, making it easy to manage and maintain, while financially feasible.
  • Scalability: RaaS allows businesses to scale their robotic workforce based on occupancy and specific needs, easily allow food service operators to scale based on business performance and adapt to seasonality fluctuations.  

Nightfood is not alone in its quest to disrupt the hospitality market, as we’re witnessing the birth of what projects to be a multi-billion-dollar industry in just a few short years.

Competition breeds excitement, which helps spotlight the entire movement and inspire investment. Alphadroid, for instance, is aiming to create accessible and user-friendly robotic solutions that empower human workers by taking over routine and physically demanding tasks. This aligns with the broader industry trend towards automation, driven by the need to address tasks which can easily be supported.

The transition to robotic solutions that assist workers by taking over routine tasks can be crucial to a pivotal change within service. For instance, “Sunny,” a robot server at Denny’s in Laurel, Maryland, helps reduce the workload during busy hours, allowing human staff to focus on more complex tasks. This example illustrates how robotics can enhance efficiency and job satisfaction when integrated thoughtfully.

The Future of Hospitality and Nightfood’s Role

Many experts believe we’ve already crossed the tipping point. The future of hospitality is written, and that future includes integrated robotics solutions. The remaining questions involve the pace of adoption and who will get left behind.

Future industry economics simply will not work without the efficiency of automation integrated into workflows. Between today and that inevitability, RaaS is the mechanism that allows the hospitality and foodservice industries to transition seamlessly into that future.

As industries pivot, changes must be made to secure efficiency and enrichment. RaaS has become a standard practice, offering a scalable task solution that enhances operations and human revision. Repetitive tasks currently performed by labor has transitioned into an improved service quality due to RaaS working harmoniously with human teams.

Nightfood Holdings’ strategic acquisition of Future Hospitality Ventures positions the company at the forefront of this technological revolution. By leveraging RaaS, Nightfood is not only addressing immediate industry challenges, but also encouraging its long-term growth and success.

As the RaaS market continues to grow, Nightfood’s investment in Future Hospitality Ventures is likely to yield significant returns. The company believes it can establish a competitive edge in the market with external forces necessitating automation and technological innovation. Through these strategic initiatives, Nightfood is not only driving significant value for its shareholders but also playing a pivotal role in shaping the future of the hospitality industry.

For more information, visit the company’s website at https://nightfood.com/

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

SuperCom Ltd. (NASDAQ: SPCB) Reports Revenue Growth with Offender Supervision Contract in Baltimore

  • SuperCom Ltd., a secure solutions provider for the e-Government, IoT and Cybersecurity sectors, capitalizes on its proprietary technology suite and experienced 24/7 services to help government clients track and identify individuals under legal supervision
  • The Israel-based company is focused on public safety through the monitoring of parolees and probation orders, domestic violence suspects and substance abuse rehabilitation patients
  • SuperCom has reported a number of new contracts in the United States and Europe this year, helping the company to recognize record gross profit growth and a move into positive territory for its bottom line
  • The offender-tracking industry provides value to society not only through security solutions, but also by reducing criminal recidivism and helping offenders to continue functioning as productive employees and family members

The growth and vitality of electronic monitoring (“EM”) technology innovator SuperCom (NASDAQ: SPCB) is reflected in the growing list of new contracts the company continues to secure, including a recently reported technology and service provision contract for an agency located near the nation’s capital.

The contract with the Baltimore-based client covers the deployment of SuperCom’s advanced GPS technology as well as its 24/7 monitoring center services. SuperCom is enhancing the service provider’s ability to legally track the movements of individuals under court-authorized supervision, such as parolees or domestic violence suspects.

“Our GPS technology and 24/7 monitoring center services are perfectly aligned to meet the needs of their clients and operations, providing robust and reliable solutions to support their mission,” SuperCom President and CEO Ordan Trabelsi stated in an Aug. 29 news release (https://ibn.fm/7qJeA). “This contract not only strengthens our footprint in the U.S. market but also reaffirms our commitment to delivering top-tier technology and services that empower our partners and clients to achieve their goals.”

Since the beginning of the year, SuperCom has announced millions of dollars in new orders from European clients on a recurring revenue basis, as well as new contracts with agencies in the United States. That includes a contract announced last month with multiple West Virginia sheriff agencies to leverage SuperCom’s PureOne technology suite for monitoring solutions in rural areas with limited cellular coverage (https://ibn.fm/nImq2).

The contract in Maryland is estimated to generate an annual recurring revenue of about $250,000 for oversight and management of offenders in the criminal justice system.

SuperCom draws on the experience of employees with the nation’s defensive technologies, giving the company an added advantage in the EM security sector. The company’s growing gross profit margins are evident in its most recent quarterly report, in which SuperCom’s executive team noted a Q2 surge in gross profit (65.2%) for a new company record, with net income growth of 183% over the previous quarter and EBITDA improving by 182% during the first half of the year.

“Our strategic focus on cost optimization and capital management, combined with our innovative approach to technology deployment, has driven a significant turnaround in our bottom line,” Trabelsi stated (https://ibn.fm/LZlOS). “Particularly noteworthy is our successful displacement of long-time incumbents in the judicial sector, showcasing the superiority of our PureOne technology. … We are excited about the opportunities ahead and believe in our ability to maintain our momentum.”

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

Clene Inc. (NASDAQ: CLNN) Seeks to Transform Neurodegenerative Disorder Treatments, with Rise in Prevalence and Associated Markets

  • With a focus on improving mitochondrial health, CNM-Au8® stands out among other therapies by targeting the nicotinamide adenine dinucleotide pathway to restore and protect neurological function.
  • Nearly 2 million Americans are affected by amyotrophic lateral sclerosis (“ALS”), multiple sclerosis (“MS”) or Parkinson’s disease.
  • The global therapeutics markets for neurogenerative diseases are projected to grow substantially, driven by the growing prevalence of these conditions, rising geriatric population and the emergence of new therapies.
  • Clene is preparing Phase 3 trials of CNM-Au8 in MS and ALS.

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, is making significant strides with its lead candidate, CNM-Au8. This innovative treatment focuses on targeting the nicotinamide adenine dinucleotide (“NAD+”) pathway, which is critical for many mitochondrial functions, including energy production and redox homeostasis. Through this novel mechanism, CNM-Au8 restores and protects neurological function, offering new hope for patients with conditions like amyotrophic lateral sclerosis (“ALS”), multiple sclerosis (“MS”) and Parkinson’s disease.

The potential market impact of CNM-Au8 is considerable, given the prevalence of these disorders. Approximately 5,000 Americans are diagnosed with ALS each year, and about 30,000 people are currently living with the disease in the U.S. alone, according to CDC statistics (https://ibn.fm/iMM9N). The global market for ALS therapeutics was valued at $537.2 million in 2018 and is expected to grow at a compound annual growth rate (“CAGR”) of 5.8% from 2019 to 2026, driven by increasing awareness, rising geriatric population and increasing incidence rate (https://ibn.fm/MgLWn). According to the National Institute of Neurological Disorders and Stroke, following gradual paralysis, patients with ALS often die from respiratory failure within 3-5 years.

MS, affecting nearly 1 million Americans and an estimated 2.9 million people worldwide, represents an even larger market. MS is a chronic disease that impacts the central nervous system, leading to a wide range of neurological symptoms. The MS therapeutics market is expected to grow significantly, expanding from $25.94 billion in 2023 at a CAGR of 5.9% from 2024 to 2030, fueled by advancements in treatment options and increased diagnostic rates (https://ibn.fm/ZHca3).

Parkinson’s disease, another key target for CNM-Au8, affects nearly 1 million people in the U.S., with 90,000 new cases diagnosed annually, and more than 10 million people worldwide (https://ibn.fm/UhyZV). The global Parkinson’s therapeutics market was valued at $4.28 billion in 2021 and is expected to expand at a CAGR of 12.1% from 2022 to 2030, driven by the increasing geriatric population, which is exposed to a high risk of developing Parkinson’s and the strong product pipeline of disease-modifying therapies (https://ibn.fm/lDbUs).

The potential of CNM-Au8 in these markets is underscored by its mechanism of action. CNM-Au8 works by improving cellular energy production and utilization, crucial for maintaining neuronal health. Mitochondrial dysfunction is a common pathway leading to neuronal death in neurodegenerative diseases. By targeting this dysfunction, CNM-Au8 aims to provide neuroprotection and promote remyelination, potentially altering the course of these debilitating conditions, providing a dual benefit that could distinguish it from existing therapies.

Clene’s advancement in this field comes at a time when the demand for innovative treatments is surging. The company is now seeking FDA feedback on a potential pathway for accelerated approval for ALS with CNM-Au8, while preparing for Phase 3 clinical trials in both ALS and MS. Driven by encouraging results in clinical trials so far and a robust safety profile with no serious adverse effects, Clene is well-positioned to make significant strides in this therapeutic landscape.

For more information, visit the company’s website at www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

Amid Record Market Highs, 2,500+ Investors Seek Timely Guidance in Toronto

More Than 60 Top Financial Experts Converging on the Metro Toronto Convention Centre North from Sept. 13-14 for MoneyShow’s “Outlook 2024-2025: Politics, Policy, & Profits” Conference

Canadian investors have had several reasons to celebrate in 2024. They include new stock market highs at home and abroad…strength in select commodities, including a move to record highs in gold…and interest rate cuts now underway domestically and globally.

Yet many questions remain. How will potential political regime shifts in Canada and the U.S. over the coming year impact their portfolios? What will changes in tax law and government programs mean for stocks and bonds? How many more times will the Bank of Canada cut rates – and what will that mean for key commodities and real estate markets?

At the MoneyShow Toronto, attendees will get the answers to all those questions and more – from dozens of North America’s leading money managers, market strategists, economists, trading educators, and acclaimed authors and columnists. They will also receive insights, guidance and recommendations for their stocks, ETFs, options, commodities, real estate, cryptocurrencies, and more.

Select keynote speakers include Larry Berman, Raghav Mehta, Eric Nuttall, Prerna Mathews, Dylan Smith, Brian Belski, and Peter Boockvar. They represent firms such as ETF Capital Management, Fidelity Canada, Ninepoint Partners LP, Mackenzie Investments, Rosenberg Research, BMO Capital Management, and Bleakley Financial Group.

More than 2,500 individuals have already registered to attend. They will enjoy two full days of presentations, panel discussions and workshops like “Stocks, Commodities, & the Economy: Where Things Stand, Where We’re Headed”…“Our Energy Realities and the Multi-Year Bull Market in Energy Stocks”…“The Only Way Is Down: Positioning for the Next Phase of the Cycle”…“Investing in the Growth Engine of the World—The Technology Arena”…and “How to Use Social Sentiment to Profit in Markets.”

MoneyShow will also host an interactive and entertaining TSX closing bell ceremony Friday, Sept. 13, sponsored by the TMX Group Ltd. (TSE: X). Plus, financial advisors will have access to a special conference track of FA-focused workshops, produced in conjunction with the Financial Planning Association of Canada and MoneySense.

The 2024 MoneyShow Toronto

Theme: Outlook 2024-2025: Politics, Policy, & Profits

Organizer:  MoneyShow

Start: Sept. 13, 2024, 9:25 a.m. Eastern

End: Sept. 14, 2024, 5:15 p.m. Eastern

Address:

Metro Toronto Convention Centre North

255 Front Street West

Toronto, ON

M5V 2W6

Price: FREE

Email: customerservice@moneyshow.com

Lexaria Bioscience Corp. (NASDAQ: LEXX) Yields “Extremely Interesting” Results for DehydraTECH(TM) Liraglutide in Ongoing Diabetes Animal Study

  • Lexaria, a global innovator in drug delivery platforms, has just announced its 4-week and 8-week blood glucose results from its WEIGHT-A24-1 animal study
  • Two formulations from the study posted outstanding performance, with each utilizing the company’s patented DehydraTECH(TM) technology
  • DehydraTECH-liraglutide (Group H) and two DehydraTECH-CBD formulations (Groups A & B) posted blood sugar level reductions of 2.50%, 1.90%, and 1.53%, respectively
  • These results build on the positive results from Lexaria’s 2023 DIAB-A22-1 animal study, which showed a 16.7% blood sugar concentration increase relative to baseline by day 56 for the obese control group that got no treatment

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its 4-week and 8-week blood glucose results from its WEIGHT-A24-1 animal study (the “study”). This study will examine diabetes and weight loss effects of DehydraTECH-processed GLP-1 drugs and DehydraTECH-processed cannabidiol, alone and in combination . The ongoing study uses diabetic, pre-conditioned Zucker rats, falling in one of three study arms, with dosing lasting 12 weeks (https://ibn.fm/uuLLk).

Two formulations posted outstanding performance from the study as of day 56 – DehydraTECH-liraglutide (Group H) and two DehydraTECH-CBD formulations (Groups A & B). Most notably, they each posted blood sugar level reductions of 2.50%, 1.90%, and 1.53% respectively. DehydraTECH-liraglutide specifically saw a -2.08% change as of day 28 and a -2.50% change as of day 56 in what Lexaria’s management described as “extremely interesting.”

For Lexaria, these results build on the positive results from its 2023 DIAB-A22-1 animal study, which showed a 16.7% blood sugar concentration increase relative to baseline by day 56 for the obese control group that received no treatment. For the current study, each of the eight active groups of animals either experienced a smaller increase or an actual decrease in blood sugar level relative to baseline compared to the obese control group in the previous study.

The ongoing study featured eight groups. Groups A through D were administered with different DehydraTECH-CBD compositions. Groups E and F utilized reformulated Rybelsus DehydraTECH compositions, whereas groups G and G used pure glucagon-like peptide-1 (“GLP-1”) drugs semaglutide and liraglutide respectively in DehydraTECH compositions. Additional results from this study are expected soon. However, Lexaria’s management remains optimistic that it will replicate both the interim and previous results, ultimately demonstrating the superiority of its DehydraTECH technology.

The global diabetes treatment market was valued at $79.25 billion in 2023. It is projected that by 2032, it will have surpassed $153 billion in valuation, mainly influenced by the growing prevalence of the condition and the increasing demand for effective drug therapies (https://ibn.fm/1mEgi). For the longest time, treatment options have involved painful injections, which, to many, have been a source of discomfort and, to some, an outright deterrent. Lexaria looks to carve out a piece of the diabetes treatment market share by offering an oral alternative and is banking on its DehydraTECH technology to achieve that. Its previous and ongoing studies are a testament to its commitment to this goal and its pledge to creating shareholder value.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

D-Wave Quantum Inc. (NYSE: QBTS) and NTT DOCOMO Leverage Quantum Optimization Technology to Boost Mobile Network Performance

  • A pilot project with Japan’s largest mobile service provider showed that the deployment of D-Wave’s annealing quantum computing solutions improved mobile network performance by 15%.
  • D-Wave’s hybrid solver was able to process a task in just 40 seconds, compared to 27 hours with a general-purpose solver.
  • The project demonstrated a significant reduction in signal congestion across base stations, which can potentially lead to more efficient transmission and cost savings.
  • This collaboration marks an important step in applying and further integrating quantum computing in telecommunications.

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the first commercial provider of quantum computers, announced the results of a quantum optimization pilot project with Japan’s mobile phone operator NTT DOCOMO Inc. (“DOCOMO”), showing demonstrable improvements in mobile network performance (https://ibn.fm/JTeGD).

During the pilot program, DOCOMO, which is the largest mobile service provider in Japan with over 90 million subscriptions, found that decreasing paging signals during peak calling times by 15% can reduce congestion at base stations. This can potentially lead to improved efficiencies and lower infrastructure costs.

DOCOMO used D-Wave’s annealing quantum computing solutions to optimize base station tracking areas that send paging signals and process extensive historical data on device movements between stations. This allows DOCOMO to predict future movement patterns and to determine the best combination of base stations to maintain and re-establish connections as devices move between tracking areas.

“We anticipate that our quantum optimization strategy will further refine network efficiency, allowing us to maintain high-quality service without additional infrastructure investments as network traffic increases,” said Takatoshi Okagawa, director of research and development strategy at NTT DOCOMO. “With D-Wave’s hybrid quantum technology, we aim to set a new standard in the telecommunications industry for operational performance.”

The pilot project included demonstration experiments at base stations in Tokai, Chugoku and Kyushu areas, and results clearly showed D-Wave hybrid-quantum technology’s efficiency compared to classical methods. More specifically, a general-purpose solver took 27 hours to complete a task in the pilot, while D-Wave’s hybrid solver took just 40 seconds for the same task.

The pilot application used a large volume of log data to optimize groups of base stations that collectively send paging signals. The hybrid solver was able to predict the number of paging signals for all base stations’ combinations simultaneously, making it possible to determine the optimal tracking area in a very short time (https://ibn.fm/Ho42V). Tests showed that quantum optimization reduced paging signals by 15%, which allowed roughly 1.2 times more terminals to be connected during peak calling times. This can minimize the number of signals, offering a safety margin for base station resources and ensuring the stability of communication quality no matter how busy the network.

Following the pilot program, DOCOMO plans to deploy the annealing quantum computing solution into production at branch offices across Japan. The company is also exploring opportunities to apply quantum optimization across all of its business units, including finance, retail, traffic and logistics, and construction.

Commenting on the results of the program, Dr. Alan Baratz, CEO of D-Wave, explained that telecommunication companies are generally faced with increasing operational complexities, including shifting consumer demand and 5G implementation, and therefore need innovative solutions to maintain their competitive edge. “DOCOMO’s successful pilot sends a clear signal — that today’s quantum technologies are capable of solving telcos’ complex optimization problems, with the potential to elevate customer satisfaction, maintain network performance and mitigate rising infrastructure costs,” Dr. Baratz added.

For more information, visit the company’s website at www.DWaveQuantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward Looking Statements

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including the risks set forth under the heading “Risk Factors” discussed under the caption “Item 1A. Risk Factors” in Part I of our most recent Annual Report on Form 10-K or any updates discussed under the caption “Item 1A. Risk Factors” in Part II of our Quarterly Reports on Form 10-Q and in our other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law.

Trillion Energy International Inc. (CSE: TCF) (OTCQB: TRLEF) Completes Perforation Program, Boosts Gas Production to 7.3 MMCF/d

  • SASB gas field is producing critical domestic supply of natural gas during Europe’s current energy crisis.
  • With all perforations now complete, West Akcakoca-1 is producing 2.8 MMcf/d using a 28/64 choke to ensure its high pressure will not back out other wells.
  • The next program phase aims to end this year with five development wells and one stratigraphic well, for a total of six producing wells.

Trillion Energy International (CSE: TCF) (OTCQB: TRLEF), a company focused on oil and natural gas production for Europe and Türkiye, has perforated all remaining gas pay in the SASB wells and has provided an update on production levels.

(The SASB gas field, which is located in the southwestern Black Sea, provides a domestic supply of natural gas to Türkiye, which is particularly critical during the current energy crisis that Europe is facing (https://ibn.fm/lGhIM).

“We have now perforated all remaining gas pay in the SASB wells,” said Trillion CEO Arthur Halleran. “We are pleased with the results. Installation of production tubing in the past required a jack-up rig, which was extremely expensive. However, we intend to run the new production tubbing without a rig using a snubbing unit, which is substantially cheaper and will provide a long-term production solution.”

The final set of perforations were on the West Akcakoca-1 well, resulting in strong pressure and initial gas flows (https://ibn.fm/6BUYL).

Trillion has previously reported on perforations of the West Akcakoca-1 well; this update notes that the well has now had the last three perforation intervals totaling 4 meters done. Previous delays caused by weather and equipment problems have been overcome, and the perforation program is now complete, with a total of five zones perforated.

Results for the perforation of West Akcakoca-1 note that the initial two perforated zones consisting of five meters of gas pay increased the well head pressure (“WHP”) from 1150 psi to 1350 psi, with the perforation of the subsequent three zones increasing WHP from 1350 psi to 1694 psi. Now, with all perforations complete, West Akcakoca-1 is producing 2.8 MMcf/d using a 28/64 choke to ensure its high pressure will not back out other wells.

“At this time, total combined production from the Akcakoca platform is 7.3 MMcf/d (100% interest), including the Guluc-2, West Akcakoca-1 and South Akcakoca-2 wells,” the company reported. “Production increases are expected as new tubing (velocity strings) are installed in the near future on additional wells.”

A conventional gas field located in the southwestern Black Sea, SASB consists of multiple conventional natural gas pools located in shallow water. The fields have produced more than 43 BCF since initial development began in 2007. Trillion began redeveloping the field in 2022 with a planned 17+/- well program; Phase B of the program outlines plans to end this year with five development wells and one stratigraphic well, for a total of six producing wells.

Trillion Energy International is focused on oil and natural gas production for Europe and Türkiye with natural gas assets in Türkiye. The company holds a 49% interest in the SASB natural gas field, a Black Sea natural gas development, and a 19.6% (except three wells with 9.8%) interest in the Cendere oil field. Trillion Energy is also pursuing oil exploration in southeast Türkiye and beyond.

For more information regarding Trillion Energy, visit the company’s website at www.TrillionEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to TRLEF are available in the company’s newsroom at https://ibn.fm/TRLEF

ECGI Holdings Inc. (ECGI) Enjoys Success of Allon Apparel Line Launch at AETA International Trade Show

  • ECGI Holdings recently reported on the success of its Allon equestrian apparel collection at the AETA International trade show
  • The Allon apparel line debuted at the trade show to a great reception by retailers and industry experts, with the company receiving positive feedback and praise for some of its designs
  • The launch included meticulously designed show coats, show shirts, breeches, safety vest covers, and jewelry, with each piece reflecting the Allon brand’s commitment to combining quality and luxury with functionality

Back in June, ECGI Holdings (OTC: ECGI), a diversified holding company with a portfolio encompassing viticulture and luxury fashion, announced that its subsidiary, Pacific Saddlery, had secured a spot at the American Equestrian Trade Association (“AETA”) International trade show. Renowned as the premier English lifestyle trade event, the AETA International trade show features industry products from leading manufacturers as well as retailers from around the world.

Leveraging the show’s status as a platform for the equestrian industry to conduct business with retailers, ECGI believed the show would be the perfect setting to introduce its new line of ready-to-wear equestrian apparel under Pacific Saddlery’s Allon brand. In addition, ECGI expected the trade show to drive significant interest and foster valuable connections within the equestrian community (https://ibn.fm/2tElQ).

With the trade show now ended, ECGI Holdings is reporting that its expectations were met, noting the success of its Allon equestrian apparel collection at AETA. The event, ECGI noted in a recent news release, drew significant attention from key retailers, providing an excellent setting for the launch of the Allon apparel line (https://ibn.fm/ELzmq).

Capturing the imagination of the attendees, the new line epitomized craftsmanship, innovative design, and style; it best illustrated Pacific Saddlery’s commitment to combining luxury and quality with functionality. The launch included a range of show coats, show shirts, breeches, safety vest covers, and jewelry, with the safety vest cover, in particular, earning much praise from both retailers and industry experts.

“The positive feedback we received, especially for our safety vest cover, reinforces our belief in the Allon brand. We are excited about the future and the role Allon will play in elevating the equestrian apparel industry,” said Jamie Steigerwald, CEO of ECGI Holdings.

ECGI believes the attendees’ overwhelming response to the new Allon apparel collection attests to its potential to redefine standards in equestrian fashion. Nick Collins, CEO of Pacific Saddlery, echoed this sentiment, saying, “Retailers are eager to bring our products to their customers and we are confident that the Allon line will set a new benchmark in the market.”

With analysts at Transparency Market Research observing that a focus on innovation and sustainability, coupled with the ability to deliver quality, functional, comfortable, and stylish apparel, is key to unlocking lucrative opportunities in the competitive equestrian apparel market, ECGI appears set on a course to future success. The company and its subsidiary aim to capture a share of this growing market, projected to reach $9.7 billion by 2031 from $6.0 billion in 2022 (https://ibn.fm/K2O1H).

ECGI also noted that Allon’s presence at the trade show resulted in the addition of several prestigious brands to Pacific Saddlery’s retail website. The listing of these brands is expected to significantly enhance the site’s offering, growing Pacific Saddlery’s status as a leading destination for luxury equestrian apparel, equipment, and accessories. The company expects to disclose details of these collaborations at a future date.

The company believes the successful launch of the Allon collection at the AETA trade show signals a bright future for the brand and the company. To facilitate the realization of this future and enable continued success, ECGI Holdings remains committed to delivering excellence and innovation as well as stylishly designed apparel that promises comfort and quality.

For more information, visit the company’s website at www.ECGIHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to ECGI are available in the company’s newsroom at https://ibn.fm/ECGI

Astiva Health Inc. Unveils New Community Outreach Initiative to Enhance Senior Wellness, Access to Care

  • The company is leveraging its extensive network of local partnerships to bring healthcare services directly into communities it serves
  • Astiva is expanding network of activity centers, which are designed to be more than just places for medical care
  • Astiva Health recognizes that true wellness goes beyond treating illness; it requires a proactive approach to health
  • One of the pillars of Astiva Health’s approach to care is cultural responsiveness

As the landscape of healthcare continues to shift toward more community-focused and personalized care, Astiva Health is launching a comprehensive community outreach initiative aimed at improving wellness and healthcare access for seniors across Southern California. This initiative represents a significant expansion of Astiva’s commitment to addressing the unique needs of its growing Medicare Advantage Prescription Drug (“MAPD”) member base.

Empowering Seniors Through Local Partnerships

Astiva Health is leveraging its extensive network of local partnerships to bring healthcare services directly into the communities it serves. By collaborating with neighborhood pharmacies, grocery stores and local organizations, Astiva is ensuring that its members can access essential services in a familiar and supportive environment. This initiative not only improves accessibility but also strengthens the bonds between healthcare providers and the communities they serve.

Expansion of Activity Centers to Promote Holistic Health

As part of this outreach initiative, Astiva is expanding its network of activity centers, designed to serve as wellness hubs. These centers will offer seniors a variety of health and wellness activities, educational seminars and social events that foster community connections while providing information about their medical insurance and benefits. The expansion will introduce new locations in underserved areas, ensuring more seniors have access to these essential resources.

Culturally Tailored Healthcare Solutions

One of the pillars of Astiva Health’s approach to care is cultural responsiveness. This initiative will also emphasize the importance of delivering healthcare that respects and understands the diverse cultural backgrounds of its members. Astiva will continue to offer multilingual services and culturally relevant health education, ensuring that all members can navigate their healthcare journey with confidence and clarity.

Building a Healthier Future for Seniors

Astiva Health’s community outreach initiative is not only about expanding services, it’s about building a healthier future for seniors in Southern California. By focusing on accessibility, preventative care, mental health and cultural sensitivity, Astiva is setting a new standard for how healthcare should be delivered to the aging population. This initiative is a testament to Astiva’s dedication to creating lasting, positive change in the lives of its members and the communities it serves.

For more information, visit the company’s website at www.AstivaHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to Astiva Health are available in the company’s newsroom at https://ibn.fm/Astiva

SuperCom Ltd. (NASDAQ: SPCB) Reports Growth in Recurring Revenues, including Inking of New EM Contracts with West Virginia Law Enforcement Agencies

  • Law enforcement agencies and court systems worldwide are increasingly turning to electronic monitoring (“EM”) solutions as a means of supervising non-violent criminal offenders without the escalating expense of incarcerating them in jail facilities
  • EM technology innovator SuperCom Ltd. is successfully marketing its PureSecurity technology suite as a superior RFID and GPS-powered solution for tracking electronically supervised individuals’ movements, recently reporting recurring contracts with multiple West Virginia sheriffs’ offices
  • SuperCom’s August report on Q2 financial gains also acknowledges recurring revenues from European government agencies served by its technologies — evidence of the company’s ability to fulfill the needs of its clients successfully
  • EM solutions are valued as a cost-saving means of providing community safety without incarceration while helping to reduce criminal recidivism and providing offenders the chance to continue working productively in society

Electronic monitoring (“EM”) and identification security solutions developer SuperCom (NASDAQ: SPCB) is increasing its recurrent contract revenue with the recent signing of agreements with multiple sheriff agencies throughout West Virginia for its monitoring technology.

The sheriffs’ offices in each of the state’s 55 counties provide constitutionally established law enforcement services that include serving as officers of their local court and jail infrastructures, helping to ensure that court-ordered judgments are enforced. The new SuperCom contracts leverage the company’s PureOne suite technology to provide robust monitoring solutions in rural areas where there is limited cellular communication coverage.

“These contracts highlight our dedication to innovation and our ability to meet the diverse needs of law enforcement agencies, especially in challenging environments,” SuperCom President and CEO Ordan Trabelsi stated in an Aug. 22 news release about the contracts (https://ibn.fm/esxeP). “The integration of PureOne’s advanced technology into these new contracts reaffirms our commitment to delivering adaptable and reliable solutions tailored to the unique needs of law enforcement agencies, particularly in rural regions with limited cellular coverage,” Trabelsi stated. “This ensures continuous and dependable service, which is essential for enhancing public safety and operational efficiency.”

SuperCom also recently secured recurring revenues and millions of dollars in new orders from European governments interested in the company’s EM tools for tracking criminal offenders. The contracts with West Virginia’s sheriffs underscore the company’s ability to successfully serve its clients with EM solutions tailored for monitoring individuals involved in justice systems throughout the United States as well as internationally.

EM technologies are being used with increasing frequency to improve judicial options regarding incarceration and associated alternatives. Offenders with a low likelihood for violence are more often allowed supervised probation within their communities as a means of reducing the financial needs of local justice systems while simultaneously aiming to reduce repeated criminal offenses of those being monitored.

Offenders and suspected offenders allowed to serve home detention have long been monitored by devices such as electronic ankle monitors. SuperCom’s technology improves on legacy solutions with RFID and GPS tracking technologies that can be worn in a covert manner to help reduce subjection to the social stigma those who are being monitored may experience at work or in their communities.

The technology is particularly adaptable to assist victims of domestic violence through monitoring of offenders’ movements and notifications via cell phone to identified victims.

SuperCom also provides solutions for a variety of traditional e-government and biometric identification services for border control, driver identification, and access to government benefits.

“Our strategic focus on cost optimization and capital management, combined with our innovative approach to technology deployment, has driven a significant turnaround in our bottom line,” Trabelsi stated when announcing the company’s Q2 financial results in August (https://ibn.fm/X30wN). “Our ability to reach gross profit margins of nearly 50% as we advance through various stages of our projects is a testament to the efficiency of our operations and the high-margin nature of our offerings.”

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Strengthens Pipeline as European Commission Grants SGX945 Orphan Status

April 17, 2026

Recognition from global regulatory authorities can serve as a powerful validation of a therapy’s potential, particularly in the rare disease space where development challenges are significant and patient needs are urgent. Soligenix (NASDAQ: SNGX) has secured that type of validation, as the European Commission granted orphan drug designation to its investigational therapy SGX945 for the […]

Rotate your device 90° to view site.